New study aims to cut pneumonia deaths with precision steroid dosing
NCT ID NCT07152587
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 26 times
Summary
This study tests whether giving the right amount of anti-inflammatory medicine (corticosteroids) can lower the high death rate (25-50%) in severe pneumonia patients in the ICU. It focuses on two specific causes: adenovirus and Pneumocystis jirovecii. About 1,500 adults will be randomly assigned to different steroid doses or standard care, and the main goal is to see who is alive after 28 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.